Diagnostic and Prognostic Value of Monocyte Distribution Width in Sepsis
DOI: https://doi.org/10.2147/JIR.S372666
IF: 4.5
2022-07-20
Journal of Inflammation Research
Abstract:Juehui Wu, 1 Laisheng Li, 1 Jinmei Luo 2 1 Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, People's Republic of China; 2 Department of Internal Medicine, Medical Intensive Care Unit and Division of Respiratory Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, People's Republic of China Correspondence: Laisheng Li, Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan Road, Guangzhou, 510080, People's Republic of China, Tel/Fax +86-20-28823350-8464, Email Jinmei Luo, Department of Internal Medicine, Medical Intensive Care Unit and Division of Respiratory Diseases, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Guangzhou, 510630, People's Republic of China, Tel/Fax +86-20-85253479, Email Monocyte distribution width (MDW) is a blood monocyte morphological parameter that can be easily detected by an automated hemocyte analyzer and can provide clinicians with important information about cell volume variability in peripheral blood monocyte populations. The United States' Food and Drug Administration and Conformite Europeenne have both been cleared for their clinical application in the detection of sepsis and developing sepsis in adult patients in the emergency department (ED). Recently, MDW has been found to have an early diagnosis and predictive value for sepsis in neonates and COVID-19 patients. Here, we summarize the findings of the studies investigating the clinical application of MDW in sepsis. Under different stimuli, especially in infectious diseases, the activation of innate immunity is the host's first defense mechanism, and the change in monocyte volume is considered an early indicator reflecting the state of activation of innate immunity. Pivotal study data from a large multicenter patient cohort showed that abnormal MDW at presentation increases the odds of sepsis, considering the combination of MDW and White Blood Cell Count (WBC) as part of a standard sepsis assessment protocol for ED, which may increase the sensitivity and specificity of sepsis diagnosis. Meanwhile, MDW shares a diagnostic performance comparable to that of conventional biomarkers (C-reactive protein and procalcitonin) in sepsis. In addition, some evidence suggests that increased MDW, both in adults and neonates, may be associated with unfavorable short- and long-term outcomes, which indicates its prognostic value in sepsis. Taken together, MDW is a parameter of increased morphological variability of monocytes in response to infection, and numerous studies have shown that MDW could be used as a valuable diagnostic and prognostic index in patients with sepsis or suspected sepsis. Keywords: monocyte distribution width, sepsis, diagnosis, prognosis, COVID-19 Sepsis is a life-threatening organ dysfunction caused by the maladjustment of the body's response to infection. Sepsis is a global public health problem that generates more than 3,000,000 hospitalizations per year. Despite advances in modern medicine, more than 5.3 million people die annually from sepsis. It remains the leading cause of death in critically ill patients in non-coronary intensive care units, with an estimated overall mortality rate of approximately 30%. It has high morbidity and mortality, especially among comorbid and hospitalized patients, 1,2 and its incidence is continuously increasing worldwide. 3 Early diagnosis and treatment of sepsis and sepsis-related organ dysfunction are critical for improving patient survival and reducing healthcare costs. 4 To improve survival, early recognition of sepsis has become the primary healthcare goal of many societies, promoting research and the development of optimal biomarkers for rapid diagnosis and assessment of the severity of sepsis-related diseases. Sepsis biomarkers vary with the pathogenesis of sepsis and knowledge of regarding it. In the 1980s, pro-inflammatory cytokines that produced SIRS (TNF, IL-1β, and IL-6) and C-reactive protein (CRP) were the most important indicators for the early hyperinflammatory phase. In the 1990s, the increased expression of CD64 on the cell during infection was discovered, and procalcitonin (PCT) was described as a marker of bacterial infections. In 2001, the International Conference on Sepsis included, for the first time, CRP and PCT as biomarkers of sepsis. In addition to these biomarkers, complete blood count (CBC) and leukocyte differential (DIFF) are the most commonly used tests in clinical laboratories, and the application of CBC+DIFF in sepsis diagnosis is common. 5 With the introduction of new technologies and the development of analyzers capable of detecting changes in three hematopoietic cell lines, hemato -Abstract Truncated-
immunology